(HBM) Hudbay Minerals - Overview
Sector: Basic Materials | Industry: Copper | Exchange: NYSE (USA) | Market Cap: 11.213m USD | Total Return: 222.5% in 12m
Avg Turnover: 134M
Qual. Beats: 0
Rev. Trend: 87.9%
Qual. Beats: 1
Warnings
Extended 1w Choppy
Tailwinds
Rs Leader, Idiosyncratic Leader, Tailwind
Hudbay Minerals Inc. (HBM) is a Toronto-based diversified mining company established in 1927. The firm manages a portfolio of exploration, development, and operational assets across North and South America, with a primary focus on copper, gold, silver, zinc, and molybdenum. A key asset in its current production profile is the 100% owned Copper Mountain mine located in British Columbia.
Operating within the Diversified Metals & Mining sub-industry, the company’s business model is highly sensitive to global industrial demand and the transition toward electrification, which requires significant copper inputs. Unlike pure-play miners, diversified operators mitigate risk by extracting precious metal by-products alongside base metals, often lowering the net cash cost of production. For a deeper look at company valuations, you may find it useful to explore the data on ValueRay.
The company underwent a corporate rebranding in 2017 and continues to focus on asset optimization within stable jurisdictions. Its strategic positioning emphasizes the extraction of concentrates for global smelting and refining markets.
- Copper price fluctuations directly impact revenue from diversified North American assets
- Constancia and Copper Mountain production volumes drive quarterly earnings performance
- Operational cost management at high-altitude mines influences overall profit margins
- Gold and silver byproduct credits significantly lower net cash costs per pound
- Regulatory stability in Peru and Canada affects long-term project development timelines
| Net Income: 658.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA -1.35 > 1.0 |
| NWC/Revenue: 17.22% < 20% (prev 28.60%; Δ -11.38% < -1%) |
| CFO/TA 0.11 > 3% & CFO 769.3m > Net Income 658.5m |
| Net Debt (117.0m) to EBITDA (1.60b): 0.07 < 3 |
| Current Ratio: 1.36 > 1.5 & < 3 |
| Outstanding Shares: last quarter (398.8m) vs 12m ago 0.77% < -2% |
| Gross Margin: 37.07% > 18% (prev 0.36%; Δ 3.67k% > 0.5%) |
| Asset Turnover: 38.20% > 50% (prev 37.97%; Δ 0.23% > 0%) |
| Interest Coverage Ratio: 16.10 > 6 (EBITDA TTM 1.60b / Interest Expense TTM 72.5m) |
| A: 0.06 (Total Current Assets 1.56b - Total Current Liabilities 1.15b) / Total Assets 6.92b |
| B: 0.09 (Retained Earnings 650.1m / Total Assets 6.92b) |
| C: 0.19 (EBIT TTM 1.17b / Avg Total Assets 6.21b) |
| D: 1.22 (Book Value of Equity 3.55b / Total Liabilities 2.91b) |
| Altman-Z'' = 3.24 = A |
| DSRI: 1.09 (Receivables 336.0m/270.9m, Revenue 2.37b/2.09b) |
| GMI: 0.97 (GM 37.07% / 36.12%) |
| AQI: 1.79 (AQ_t 0.09 / AQ_t-1 0.05) |
| SGI: 1.13 (Revenue 2.37b / 2.09b) |
| TATA: -0.02 (NI 658.5m - CFO 769.3m) / TA 6.92b) |
| Beneish M = -2.42 (Cap -4..+1) = BBB |
As of May 30, 2026, the stock is trading at USD 29.16 with a total of 4,828,994 shares traded.
Over the past week, the price has changed by +17.87%,
over one month by +29.83%,
over three months by +2.96% and
over the past year by +222.51%.
Hudbay Minerals has received a consensus analysts rating of 4.68. Therefore, it is recommended to buy HBM.
- StrongBuy: 13
- Buy: 6
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 32.5 | 11.6% |
P/E Trailing = 16.9042
P/E Forward = 15.748
P/S = 4.4499
P/B = 2.9889
P/EG = 2.09
Revenue TTM = 2.37b USD
EBIT TTM = 1.17b USD
EBITDA TTM = 1.60b USD
Long Term Debt = 536.9m USD (from longTermDebt, last quarter)
Short Term Debt = 502.8m USD (from shortTermDebt, last quarter)
Debt = 1.12b USD (from shortLongTermDebtTotal, last quarter) + Leases 55.7m
Net Debt = 117.0m USD (calculated: Debt 1.12b - CCE 1.01b)
Enterprise Value = 11.3b USD (11.2b + Debt 1.12b - CCE 1.01b)
Interest Coverage Ratio = 16.10 (Ebit TTM 1.17b / Interest Expense TTM 72.5m)
EV/FCF = 44.85x (Enterprise Value 11.3b / FCF TTM 252.6m)
FCF Yield = 2.23% (FCF TTM 252.6m / Enterprise Value 11.3b)
FCF Margin = 10.64% (FCF TTM 252.6m / Revenue TTM 2.37b)
Net Margin = 27.75% (Net Income TTM 658.5m / Revenue TTM 2.37b)
Gross Margin = 37.07% ((Revenue TTM 2.37b - Cost of Revenue TTM 1.49b) / Revenue TTM)
Gross Margin QoQ = 48.59% (prev 36.85%)
Tobins Q-Ratio = 1.64 (Enterprise Value 11.3b / Total Assets 6.92b)
Interest Expense / Debt = 6.45% (Interest Expense 72.5m / Debt 1.12b)
Taxrate = 43.51% (147.5m / 339.0m)
NOPAT = 659.7m (EBIT 1.17b * (1 - 43.51%))
Current Ratio = 1.36 (Total Current Assets 1.56b / Total Current Liabilities 1.15b)
Debt / Equity = 0.32 (Debt 1.12b / totalStockholderEquity, last quarter 3.55b)
Debt / EBITDA = 0.07 (Net Debt 117.0m / EBITDA 1.60b)
Debt / FCF = 0.46 (Net Debt 117.0m / FCF TTM 252.6m)
Total Stockholder Equity = 3.18b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.60% (Net Income 658.5m / Total Assets 6.92b)
RoE = 20.72% (Net Income TTM 658.5m / Total Stockholder Equity 3.18b)
RoCE = 31.43% (EBIT 1.17b / Capital Employed (Equity 3.18b + L.T.Debt 536.9m))
RoIC = 10.53% (NOPAT 659.7m / Invested Capital 6.26b)
WACC = 12.57% (E(11.2b)/V(12.3b) * Re(13.46%) + D(1.12b)/V(12.3b) * Rd(6.45%) * (1-Tc(0.44)))
Discount Rate = 13.46% (= CAPM, Blume Beta Adj.) -> capped to 13.17%
Shares (quarterly) Correlation: 91.11 | Cagr: 6.09%
[DCF] Terminal Value 60.60% ; FCFF base≈261.7m ; Y1≈244.6m ; Y5≈224.6m
[DCF] Fair Price = 4.96 (EV 2.09b - Net Debt 117.0m = Equity 1.97b / Shares 397.2m; r=12.57% [WACC]; 5y FCF grow -8.23% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.52 | # QB: 0
Revenue Correlation: 87.91 | Revenue CAGR: 20.02% | SUE: 1.54 | # QB: 1
EPS current Quarter (2026-06-30): EPS=0.34 | Chg30d=-12.55% | Revisions=-33% | Analysts=8
EPS next Quarter (2026-09-30): EPS=0.45 | Chg30d=-6.74% | Revisions=-33% | Analysts=7
EPS current Year (2026-12-31): EPS=1.58 | Chg30d=-6.31% | Revisions=-17% | GrowthEPS=+135.5% | GrowthRev=+33.2%
EPS next Year (2027-12-31): EPS=2.10 | Chg30d=-3.63% | Revisions=+0% | GrowthEPS=+32.9% | GrowthRev=+14.0%
[Analyst] Revisions Ratio: -33%